Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments-Reference-Cited by-同舟云学术

Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments

Published:2013-06-13 Issue:2 Volume:72 Page:369-378
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Pauley Jennifer L.,Panetta John C.,Crews Kristine R.,Pei Deqing,Cheng Cheng,McCormick John,Howard Scott C.,Sandlund John T.,Jeha Sima,Ribeiro Raul,Rubnitz Jeffrey,Pui Ching-Hon,Evans William E.,Relling Mary V.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-013-2206-x/fulltext.html

Reference42 articles.

1. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV (2009) Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730–2741

2. Pui CH, Pei D, Sandlund JT, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Campana D, Kun LE, Jeha S, Cheng C, Howard SC, Metzger ML, Bhojwani D, Downing JR, Evans WE, Relling MV (2010) Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 24:371–382

3. Conter V, Arico M, Basso G, Biondi A, Barisone E, Messina C, Parasole R, De Rossi G, Locatelli F, Pession A, Santoro N, Micalizzi C, Citterio M, Rizzari C, Silvestri D, Rondelli R, Lo Nigro L, Ziino O, Testi AM, Masera G, Valsecchi MG (2010) Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 24:255–264

4. Moricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, Ludwig WD, Ritter J, Harbott J, Mann G, Klingebiel T, Zintl F, Niemeyer C, Kremens B, Niggli F, Niethammer D, Welte K, Stanulla M, Odenwald E, Riehm H, Schrappe M (2010) Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 24:265–284

5. Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, Sather HN, Hunger SP, Devidas M (2010) Long-term results of the children’s cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: a children’s oncology group report. Leukemia 24:285–297

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study;British Journal of Haematology;2024-03-03

2. Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children’s Research Hospital;Cancer Chemotherapy and Pharmacology;2024-02-28

3. Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing;CPT: Pharmacometrics & Systems Pharmacology;2023-10-12

4. Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia;Leukemia;2023-08-05

5. Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma;Pediatric Hematology and Oncology;2023-05-17